Eight in 10 Brits have experienced chronic aches and pains – with a third admitting their lives are currently ‘on hold’ as a result.
4 Articles
4 Articles
Eight in 10 Brits have experienced chronic aches and pains – with a third admitting their lives are currently ‘on hold’ as a result.
A poll of 2,000 adults revealed over half (53 per cent) have suffered discomfort for more than a year, with 24 per cent claiming aches and pains had stopped them from doing what they enjoy in life and a quarter saying they have had to stop working.
Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies
By Meg Flippin Benzinga DETROIT, MICHIGAN - April 23, 2025 (NEWMEDIAWIRE) - Lance Alstodt, CEO of BioRestorative Therapies (NASDAQ: BRTX), was recently a guest on Benzinga’s All-Access. BioRestorative Therapies is a regenerative medicine company that wants to alleviate chronic lower back pain, obesity and diabetes and is developing stem cell therapies to meet that end. The company’s flagship program, BRTX-100, which is in a phase 2 clinical tri…
BioRestorative Therapies Advances Stem Cell Treatments for Chronic Pain and Metabolic Disorders
BioRestorative Therapies, a regenerative medicine company, is making significant strides in developing stem cell therapies to combat chronic health challenges. The company’s two primary research programs, BRTX-100 and ThermoStem®, represent promising approaches to addressing complex medical conditions that impact quality of life for numerous patients. The BRTX-100 program, currently in phase 2 clinical trials, focuses on alleviating chronic lowe…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage